Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.
Saved in:
| Title: | Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials. |
|---|---|
| Authors: | Papi, Alberto1 (AUTHOR) ppa@unife.it, Greening, Neil J1,2 (AUTHOR), Bhatt, Surya P3 (AUTHOR), Roche, Nicolas4 (AUTHOR), Celli, Bartolome5 (AUTHOR), Wedzicha, Jadwiga A6 (AUTHOR), Agustí, Àlvar7,8,9,10 (AUTHOR), Tal-Singer, Ruth11 (AUTHOR), Han, MeiLan K12 (AUTHOR), Janssens, Wim13 (AUTHOR), Hanania, Nicola A14 (AUTHOR), Nair, Parameswaran15,16 (AUTHOR), Bremner, Peter17 (AUTHOR), Porpodis, Konstantinos18 (AUTHOR), Shibata, Yoko19 (AUTHOR), Korn, Stephanie20,21 (AUTHOR), Yang, Ting22 (AUTHOR), Gordon, Oliver23 (AUTHOR), Saenz, Rebecca24 (AUTHOR), Ng, Julie24 (AUTHOR) |
| Source: | Lancet. May2026, Vol. 407 Issue 10543, p2027-2039. 13p. |
| Database: | Business Source Ultimate |
| ISSN: | 01406736 |
|---|---|
| DOI: | 10.1016/S0140-6736(26)00637-9 |
